Reviews
A. S. Alexandrov, N. A. Alexandrov
Endocronology and Internet
M. Orbetzova
Carbohydrate and Lipid Disturbances
in Certain Hypothalamo-hypophyseal
Diseases. III. Cushing’s Syndrome
Original Articles
V. Todorov, A. Tomova, S. Maximova
Anthropological Measurements in Patients
with Marfan’s Syndrome
M. Petkova, P. Dukova-Peneva, M. Boyanov
Biochemical Markers of Bone Turnover
in Type 1 Diabetes Mellitus Patients
G. Kirilov, A. Tomova, L. Dakovska,
Ph. Kumanov
Plasma Levels of Endothelin-1 in Patients
with Cushing’s Syndrome
P. Karatodorova, L. Koeva
The Endothelin - an Early Marker for
Endothelial Dysfunction
in Insulinresistant States
Chronicle
R. Yelow and S. Berson - Their Dicovery
of Radioimmunoassay
Calendar
Instructions to Authors
Endocrinology and Internet
A. S. Alexandrov, N. A. Alexandrov*
Institute of Biophysics, Bulgarian
Academy of Sciences - Sofia
*Chemical Faculty, University “Sv.
Kliment Ohridski” - Sofia
Abstract
Internet is a worldwide network of computers,
connecting million of machines and numerous small computer-nets. This is
a review presenting a concise description of the basic Internet idea (definitions,
structure, net-support), with emphasis laid on the issue how, and by what
means the information of endocrinology is represented in the net. Appendix
A submits a list of well known Internet sources (Web sites and newsgroups)
described in the article. Appendix B contains an Internet glossary of some
common computer terms. The review is based only on web sites in both English
and Bulgarian the authors are familiar with.
KEY WORDS: Internet, endocrinology, Web
sites.
Carbohydrate and Lipid Disturbances
in Certain Hypothalamo-hypophyseal
Diseases. III. Cushing's Syndrome
M. Orbetzova
Clinical Center of Endocrinology and
Gerontology,
Medical University - Sofia
Abstract
The important implications of glucocorticoids
in intermediary metabolism is a universally estabilished fact, and even
their name derives from the properties to control blood sugar level in
various conditions of the organism by assuming a protective role against
hypoglycemia. Glucocorticoids stimulate glycogen synthetase, enhance glycogen
deposits in the liver, and decrease the activity of key glycolytic enzymes.
Their chief action includes activation of gluconeogenetic enzymes and reduction
of glucose transport through cell membranes, as well as tissue glucose
uptake and utilization. Glucocorticoids antagonize insulin effects by a
mechanism still not well enough clarified. Presumably, glucocorticoid-induced
insulin resistance is most likely attributable to post-binding defects.
As regards glucocorticoid influence on lipid metabolism, the data available
are scanty and conflicting. Their predominant effect at adipocyte
level is enhanced lipolysis resulting in glycerol and nonesterified fatty
acids' release.
Cushing's syndrome serves as an endogenous
model of chronic glucocorticoid excess associated with insulin resistance
and metabolic disorders whose further elucidation will contribute to gain
better insight into insulin resistance pathophysiology in general.
KEY WORDS: glucocorticoids, ACTH, Cushing's
syndrome, carbohydrate metabolism, diabetes mellitus, lipid metabolism,
dyslipidemia.
Anthropological Measurements
in Marfan's Syndrome Patients
V. Todorov, A. Tomova, S. Maximova
Clinical Center of Endocrinology and
Gerontology,
Medical University - Sofia
Abstract
This is a report on five men and two women,
presenting the rarely encountered Marfan's syndrome, studied by evaluating
a number of anthropometric parameters. In the study group 13 basic anthropometric
parameters are assessed and compared to their counterparts in age-matched
normal subjects. Analysis of the results points to significantly elevated
values in terms of stature, trochanteric height, bihumeral and bitrochanteric
diameters, arm length, arm span length, arm span index and foot length
among male patients, and stature, arm length and arm span length among
female patients. However, in both men and women the stature/trochanteric
height and bihumeral/bitrochanteric diameter ratios do not show noteworthy
differences. Only the arm length/stature ratio in the patients group is
greater. Regardless of the changes in absolute values of the parameters
assayed, the correlations between the latter hardly justify to assume a
significant disproportion in body development on the ground of the case
material being examined.
KEY WORDS: Marfan's syndrome, anthropometric
parameters, body proportions.
Biochemical Bone Turnover
Markers in Type 1 Diabetes
Mellitus Patients
M. Petkova, P. Dukova-Peneva*, M. Boyanov**
Diagnostic and Consultative Center
“St. Luka” - Sofia
*Department of Clinical Laboratory,
Hospital “Maitchin Dom”
**Endocrinology Clinic, Alexandrov's
Hospital
Medical University - Sofia
Abstract
It is a well established fact that type
1 diabetes mellitus gives rise to osteopenia. It is the purpose of the
report to assay the biochemical markers of bone turnover and bone remodelling
in type 1 diabetic patients. Fourteen male and 13 female type 1 diabetic
patients are studied. The bone turnover markers measured include: serum
osteocalcin (OC), serum C-terminal procollagen type I propeptide (PICP),
urinary deoxypyrydinoline (DPD) and hydroxyproline (OH-Pro). Forearm
bone mineral density is measured by single x-ray absorptiometry. Mean bone
density values are within the range of osteopenia (T-score - 82,5-86,5%).
Lower than normal values are found for sOC and PICP, and elevated ones
- for urinary Ca2+/Creat. ratio. Urinary OH-Pro excretion is significantly
higher in microalbuminuric patients, as compared to normoalbuminuric ones.
The obtained results suggest that reduced bone formation is the primary
bone metabolism disorder in type 1 diabetes patients. Increased OH-Pro
excretion in microalbuminuria is most likely due to fibrogenesis enhancement.
Further prospective studies along this line are needed.
KEY WORDS: type 1 diabetes mellitus, forearm
bone density, biochemical bone turnover markers.
Plasma Levels of Endothelin-1
in Patients with Cushing's Syndrome
G. Kirilov, A. Tomova, L. Dakovska,
Ph. Kumanov
Clinical Center of Endocrinology and
Gerontology,
Medical University - Sofia
Abstract
Over the past decade, numerous experimental
and clinical data have been published demonstrating the importance of endothelin
as a modulator of hypothalamic-pituitary-adrenal axis function. Its pathophysiological
implications are suspected in a number of adrenal disorders, such as: primary
hyperaldosteronism, pheocromocytoma and adrenocortical insufficiency. For
the first time in this study plasma endothelin-1 (ET-1) concentration is
measured in 13 untreated patients with Cushing's syndrome - 8 men and 5
women at mean age 44.2±9.5 y - of which 10 with Cushing disease
and 3 with corticosteroma, duely diagnosed. In the patients with Cushing
syndrome ET-1 shows a significant 3-fold increase, as compared to healthy
controls (n=15): 1.59±0.78 vs 0.46±0.20 fmol/ml at p<0.001.
In those presenting corticosteroma ET-1 is insignificantly increased by
comparison with Cushing disesase cases (1.84±0.67 vs 1.51±0.83
fmol/ml at p>0.05). In 3 patients dying of severe cardiovascular complications,
plasma ET-1 is significantly higher than in the remainder (2.34 ±0.35
fmol/ml at p<0.05. A positive correlation is established between hipercholesterolemia
(6.94 ±1.75 mmol/l) and hyperendothelinemia among the patients:
r=+0.73, p<0.02. However, there is no correlation between ET-1 level
and arterial hypertension (183±37/106±18 mmHg), plasma cortisol
levels (16.5±2.7 mg/dl) and urinary cortisol excretion (530.5±263.5
mg/24h).
As clearly shown by the results, the endothelin
system in Cushing syndrome is markedly activated. Hyperendothelinemia is
most likely implicated in the pathogenesis of accelerated and premature
atherosclerosis development in this condition. Plasma ET-1 level in Cushing
syndrome along with other biochemical parameters may serve as a marker
pointing to endothelial dysfunction and increased cardiovascular risk.
KEY WORDS: diabetes mellitus, endothelin,
Cushing syndrome, endothelial dysfunction.
The Endothelin - an Early Marker
for Endothelial Dysfunction
in Insulinresistant States
P. Karatodorova, L. Koeva
Department of Endocrinology and Metabolic
Diseases,
Medical University - Varna
Abstract
Diabetes mellitus is a disease associated
with a multitude of metabolic abnormalities which indirectly or directly
influence the endothelium of the vascular wall. Most of the late complications
of diabetes reflect and result from microvascular dysfunction. Endothelin,
as a product of endothelial cells is one of the circulating markers of
endothelial dysfunction. Significant and diverse changes in its concentration
can be seen in conditions like diabetes and X - syndrome. The present review
examines some aspects of the synthesis and biological effects of endothelin
as well as its relations to some of the the crucial metabolic factors
in diabetes (blood glucose, plasma lipids, insulin).
KEY WORDS: diabetes mellitus, endothelin,
endothelial dysfunction. |